Awards & Recognition

FierceBiotech named Confo Therapeutics as one of its "Fierce 15" biotech companies of 2019.

Our commitment to the development of transformative GPCR-modulating therapeutics has resulted in the following accolades:

One of Fierce Biotech’s “Fierce 15”
Biotech Companies of 2019

Winner of the 2019 EuropaBio Awards
(Healthcare Biotech category)

Winner of the 2019 M&A Awards
(Best Venture Capital Deal 2019 – Life Sciences)

Finalist of the 2019 European Lifestars Awards
(Deal of the Year and Series A Finance Raise of the Year categories)

Finalist of the 2019 Belgian Venture Association Awards
(Venture Company category)

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.